The researchers call the new device design Integrascop.

Saliva and urine.concentrations of protein may indicate cell and tissue damage, inflammation, kidney failure, or an immune system, the antibody is pumped due to an infection or an autoimmune disease. Low protein levels can indicate malnutrition or the presence of diseases that prevent the body from manufacturing enough blood protein.. This self-help mixing action that speeds up the diagnostic process so that detection can occur in less than two minutes, he said.Measuring general healthSince the liquid sample is integrated with the simple LEDs and microelectronics, the researchers call the new device design Integrascop.Garcia and Schneider high several laboratory prototype devices based embodiment embodiment and demonstrates how the apparatus can be used to C-reactive protein in the human serum, which is an indicator for a variety of inflammatory conditions to measure to measure when the protein in values.

The surface has a small recess , which holds the liquid sample so that it forms so that it forms a spherical drop.

Marquez, an entrepreneur and adjunct faculty member in the School of Biological and Health Systems Engineering, is president and research leader of the company YNANO. The company specializes in droplet form – nanotechnology for biomedical applications, including Integrascop for disease diagnosis. I am excited about the potential for this device, and that the students are directly involved in the research and development process, Marquez said.Indicates that it was against your extra beliefs.The survey even that the young people were ‘almost anywhere fear of pregnancy and sexually transmitted infection, ‘Gray added that the concern have no influence on their decision to the following year in to next year.

The concentrations in CSF of several proteins that are associated with Alzheimer’s illness were measured.

The the League the League the Friends the Technical University Munich and Commission on Clinical Research of law the Isar Munich the hospital.

The investigators found to the best predictor, from 1 to 42 Alzheimer’s disease to develop combination of of sAPP, the tau protein and that age of the individual had? Where such factors have been combined the results were some 80 % accurate in predicting if the disease developing. Said protein amyloid beta1-42 or A 1-42, which previous been a biomarker for Alzheimer’s disease not a predictive factor in this study. These findings suggest that of sAPP as biomarker can helpful and above the established marker O 1-42 in early diagnosis of Alzheimer ‘s disease, say Perneczky..